International Advisory Committee on Clinical Trials in Multiple Sclerosis 2023, ' Multiple sclerosis progression : time for a new mechanism-driven framework ', The Lancet Neurology, vol. 22, no. 1, pp. 78-88 . https://doi.org/10.1016/S1474-4422(22)00289-7
Thompson, A J, Carroll, W, Ciccarelli, O, Comi, G, Cross, A, Donnelly, A, Feinstein, A, Fox, R J, Helme, A, Hohlfeld, R, Hyde, R, Kanellis, P, Landsman, D, Lubetzki, C, Marrie, R A, Morahan, J, Montalban, X, Musch, B, Rawlings, S, Salvetti, M, Sellebjerg, F, Sincock, C, Smith, K E, Strum, J, Zaratin, P & Coetzee, T 2022, ' Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal ', Multiple Sclerosis Journal, vol. 28, no. 1, pp. 16-28 . https://doi.org/10.1177/13524585211059766 Multiple Sclerosis (Houndmills, Basingstoke, England)